Cyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K
Cyxone (publ), a biotech company in autoimmune diseases announces that the European Patent Office (EPO) has issued an intention to grant communication for a unitary patent of the divisional EP-Divisional Patent Application 18 172 126.7 entitled Cyclotides as immunosuppressive agents. The patent covers the protection of the drug candidate T20K that Cyxone licenses from the Medical University of Vienna and the University of Freiburg.The European patent office announced that the patent application will be granted as a unitary patent as of November 1[st], 2023, and will be valid in the
Sweden-based semiconductor manufacturer SweGaN has chosen AFRY to provide support and expertise in several disciplines for establishing their new headquarters and semiconductor production facility in Linköping, Sweden.Supplier of semiconductor epiwafers, SweGaN, recently began the transformation from start-up to scale-up. AFRY is assisting SweGaN’s scale-up journey with a wide variety of services to build a new state-of-the-art production facility in Linköping. A rapidly growing global sector, semiconductors – are key component within electric vehicles, solar inverters, power supplies and
